| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.06 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.51 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |